EUVIMEDEUVIMED entdecken
Crossref

Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity

Daowei Zhang, Fangyuan Hu, Ting Li, Hongli Liu, Qian Li, Yun Cheng, Xuejin Zhang, Ping Xu, Shenghai Zhang, Jihong Wu

Experimental Eye Research · 2025-06 · 255 · 110352

DOI: 10.1016/j.exer.2025.110352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental Eye Research, 2025-06. Verfasst von Daowei Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Retinal Ganglion Cells, Microglia, Glaucoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Shanghai Municipal Health Commission, National Key Research and Development Program of China, National Key Research and Development Program of China Stem Cell and Translational Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glaucoma, a progressive optic neuropathy characterized by RGC degeneration and irreversible vision loss, currently affects approximately 76 million individuals globally. Despite conventional therapeutic strategies primarily targeting IOP reduction, the ongoing progression of vision loss in normotensive patients highlights an urgent need for alternative neuroprotective interventions. We employed a comprehensive experimental paradigm that integrated both in vivo and in vitro approaches. The in vivo component was utilized by NMDA-induced excitotoxicity involving Sprague-Dawley rats. In vitro analyses were conducted using R28 and BV2 cells. Quantitative assessments encompassed electroretinography, RGC survival, axonal integrity measurements, inflammatory marker profiles, flow cytometry, as well as molecular pathway analyses through immunofluorescence microscopy, Western blot analysis. Administration of PF4 (500 ng/ml) exhibited significant neuroprotective efficacy via multiple cellular mechanisms. Quantitative analyses indicated substantial preservation of RGC density (p < 0.001) alongside maintenance of inner plexiform layer thickness(p < 0.05) within the NMDA-induced model. PF4 treatment markedly attenuated microglial activation (p < 0.01) while modulating the inflammatory response-characterized by reduced expression of pro-inflammatory cytokines coupled with enhanced production of anti-inflammatory mediators. CTB tracing confirmed the preservation of both RGC axons and their projections. Molecular analyses revealed that PF4 may exerted its effects on RGC through different mechanisms: suppression of the Galectin-3/NLRP3-inflammasome/Caspase-1 pathway in microglia and enhancement of the CaMKII/CREB/BDNF neuroprotective cascade within RGCs; these protective effects can attenuate necroptosis independent from IOP modulation in retinal excitotoxicity. Our findings suggest that PF4 can protect RGCs through activate CaMKII/CREB/BDNF pathway induced by excitotoxicity. Moreover, it attenuates NLRP3 inflammasome activation via mediating Galectin-3 and thus decreasing necroptosis of RGCs. This study demonstrates that PF4 may possesses neuroprotective properties through simultaneous modulation across multiple cellular pathways in glaucomatous neurodegeneration, and emphasized the significance of immune-mediated mechanisms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Retinal Ganglion CellsMicrogliaGlaucomaAnimalsRats, Sprague-DawleyRatsDisease Models, AnimalElectroretinographyN-MethylaspartateMaleNeuroprotective AgentsBlotting, WesternCell SurvivalFlow CytometryInflammationCells, Cultured

Stichwörter der Autor:innen

NeuroinflammationPF4RGCRetinal excitotoxicity

Substanzen

N-MethylaspartateNeuroprotective Agents

Autor:innen und Institutionen

  • Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China.
  • Eye Institute, Eye and ENT Hospital, College of Medicine, Fudan University, Shanghai, China; Shanghai Key Laboratory of Visual Impairment and Restoration, Science and Technology Commission of Shanghai Municipality, Shan…

Förderung

  • Shanghai Municipal Health Commission
  • National Key Research and Development Program of China
  • National Key Research and Development Program of China Stem Cell and Translational Research

Zitieren

APA

Zhang, D., Hu, F., Li, T., Liu, H., Li, Q., Cheng, Y., Zhang, X., Xu, P., Zhang, S., & Wu, J. (2025). Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity. Experimental Eye Research, 255, 110352. https://doi.org/10.1016/j.exer.2025.110352

Vancouver

Zhang D, Hu F, Li T, Liu H, Li Q, Cheng Y, et al. Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity. Experimental Eye Research. 2025;255:110352. doi:10.1016/j.exer.2025.110352

BibTeX
@article{Zhang2025,
  author = {Zhang, Daowei and Hu, Fangyuan and Li, Ting and Liu, Hongli and Li, Qian and Cheng, Yun and Zhang, Xuejin and Xu, Ping and Zhang, Shenghai and Wu, Jihong},
  title = {Platelet factor 4 attenuates inflammation of microglia and protects retinal ganglion cells in retinal excitotoxicity},
  journal = {Experimental Eye Research},
  year = {2025},
  volume = {255},
  pages = {110352},
  doi = {10.1016/j.exer.2025.110352}
}
Kostenlos starten →